chatbot ChatGPT Lifted up artificial intelligence (AI) The surging tide of revolution, from the perspective of economic development, AI How profound will the revolution have an impact on China's economy and capital market, as well as productivity? / How should we view the impact on production efficiency? Is it ultimately possible to significantly boost the profitability of listed companies? China's development AI What major obstacles or challenges may be encountered during the technology phase? In terms of policy, will China introduce a continuous stream of significant policies to drive progress in the future? AI development?   What challenges and opportunities will traditional Chinese internet giants face?   Frost & Sullivan Frost & Sullivan Lu Jing, Partner and Managing Director of Frost & Sullivan's Greater China region, was interviewed by Lufuot about the development trends of artificial intelligence in China. Reuters News Q From the perspective of economic development, what do you think AI How profound will the revolution have an impact on China's economy and capital market, as well as on productivity? / What is the impact on production efficiency? Is it ultimately possible to significantly increase the profitability of listed companies? Witnessing the drive by artificial intelligence AlphaGo Defeating the world Go champion and last year ChatGPT After its sudden emergence, the phenomenonally explosive popularity of artificial intelligence has become an important milestone in the history of human civilization development. Similarly, this revolution driven by artificial intelligence will also have a profound impact on China's economy and capital market.   Firstly, artificial intelligence will significantly improve China's productivity, and the enhancement of production efficiency is gradually upgrading from perceptual intelligence to cognitive intelligence. Perceptual intelligence refers to the ability of computers and different devices to possess human-like perceptual abilities such as vision, hearing, and touch. By structuring and processing multi-source heterogeneous data and communicating with humans through these abilities, the efficiency improvements brought about by perceptual intelligence are already quite common in our daily lives, including face recognition in various scenarios and interactions with digital humans. Cognitive intelligence, on the other hand, draws inspiration from brain-like research and cognitive science based on perceptual intelligence. It combines cross-disciplinary knowledge graphs and other technologies to endow computers and different devices with human-like thinking and cognitive abilities. It is expected that with large-scale pre-trained language models and similar ChatGPT As the products continue to mature, the efficiency improvements brought about by cognitive intelligence will become more widespread.   Secondly, in the long run, the efficiency improvements brought about by artificial intelligence will lead to a transformation in China's labor force structure. Perceptual intelligence will replace low-skilled jobs to a certain extent (including security, telephone customer service, etc.), and such transformations have already been evident in China's business environment. Cognitive intelligence will replace repetitive skill jobs that require simple mental effort to a certain extent (including translation, graphic design, etc.).   Finally, from the perspective of its impact on the capital market, the improvement in labor efficiency and structural transformation of the workforce will be reflected in the capital market. Capital will flow into sectors and enterprises that have the greatest development potential, the most positive impact on human civilization, and that align with the direction of national policy formulation in this artificial intelligence revolution.   The impact on production efficiency is certain. As mentioned earlier, artificial intelligence technologies based on perceptual and cognitive intelligence will continuously improve the efficiency of different tasks. From the perspective of cost reduction and efficiency enhancement brought about by artificial intelligence, it will effectively help listed companies reduce operating costs, including sales expenses and management fees, thereby improving the net profit performance of listed companies and having a positive impact on listed enterprises and the entire capital market. Q China's development AI What major obstacles or challenges may be encountered in technology? In terms of policy, will China introduce a continuous stream of significant policies to drive this forward in the future?   From a technical perspective, computing power, as an important infrastructure for the development of artificial intelligence, especially during the recent phase of concentrated development of large-scale pre-trained language models, has reached a certain level of demand in China. Moreover, the development of computing power will directly affect the level of advancement of artificial intelligence technology in our country. Data is the key to algorithm models, especially when developing large-scale language models, special attention needs to be paid to issues related to personal information protection, including data sources, data processing, data security, and bias induction. Taking models from leading foreign manufacturers as an example, CodeBert , LAMDA Subsequently, there have been revelations of biased, discriminatory, or inappropriate content, including derogatory remarks towards certain groups or distortions in the content or timing of certain topics. The occurrence of such issues is often due to data sources, and the quality of the data sources largely determines the excellence of the model.   From a policy perspective, there is no doubt that China's encouragement for the development of artificial intelligence is substantial. 2017 The "New Generation Artificial Intelligence Development Plan" issued by the State Council in [year] specifically mentions 2025 In the coming year, major breakthroughs should be made in the basic theories of artificial intelligence. Some technologies and applications should reach world-leading levels. Artificial intelligence should become the main driving force for industrial upgrading and economic transformation in China. Active progress should be made in the construction of an intelligent society. It is particularly proposed that the scale of the core artificial intelligence industry should exceed 4,000 Yuan, driving the scale of related industries to exceed 5 trillion yuan; by 2030 In 2023, the overall theory, technology, and application of artificial intelligence should reach the world's leading level, becoming a major global center for artificial intelligence innovation. The intelligent economy and society should achieve significant results, laying an important foundation for China to rank among the forefront of innovative countries and become an economic powerhouse. Among these, the scale of the core artificial intelligence industry should exceed 1 trillion yuan, driving the scale of related industries to exceed 10 trillion yuan. In addition, in response to the specific challenges mentioned earlier, our country has also introduced a series of development policies. Taking 'East Data West Computing' as an example: 2021 year 5 month 24 On the same day, four ministries and commissions jointly issued the "Implementation Plan for the National Integrated Big Data Center Collaborative Innovation System Computing Power Hub," proposing the layout and construction of national integrated computing power network hub nodes, accelerating the implementation of the "East Data West Computing" project. Further network transmission channels will be opened up between national hub nodes to improve cross-regional computing power scheduling levels. Exploration and practice in cloud computing services, data circulation, data applications, security assurance, etc., will be strengthened to play a demonstrative and leading role, providing important assistance in solving China's computing power needs for artificial intelligence. Q What significant challenges and opportunities will traditional Chinese internet giants face?   In fact, during the development of artificial intelligence in our country, traditional Chinese internet giants (which are what we commonly refer to as Alibaba, Baidu, Tencent, Douyin Group, and JD.com) have not been absent. They have even become important participants in the infrastructure and application aspects of artificial intelligence in our country. Take Baidu as an example, 2018 Announced in “ All In AI After the strategic launch, Baidu has taken the lead in delivering a remarkable result in this year's large-scale language model competition. Although there is still room for improvement compared to foreign models, as a domestic vendor, it has made up for the shortcomings of foreign models in the Chinese language corpus environment. Baidu's Wenxin Large Model can generate excellent works for different fields based on different keyword and scenario requirements. For example, it can generate a beautiful painting by inputting a sentence or a description of text. 2022 year 7 In January, the Wenyang-textile-textile Large Model "completed" the missing scroll of the world-famous painting "The Song of Rich Spring," and also composed a poem, which elicited exclamations from everyone. After Baidu released the Wenxin Large Model, Alibaba Cloud also launched a large language model with hundreds of billions of parameters, "Tongyiquanwen" Integrating multimodal knowledge understanding, it possesses strong copywriting capabilities, and these abilities are applied to empower the office collaboration software DingTalk under Alibaba. DAMO Academy, an R&D institution under Alibaba, has always been at the forefront of artificial intelligence technology research in China, dedicated to exploring the unknown through technology and driven by human aspirations, conducting basic scientific research and innovative technology development. We believe that traditional internet giants have always been actively involved in the development of artificial intelligence in our country and will continue to be at the forefront of technological development. * This interview was published in Refinitiv Workspace   Reporters: Liu Luoyan, Lin Yuhuan. Original title: 'Analysis' AI The 'arms race' is in full swing, and China needs to break through the 'iron curtain' of technology    .

Recently, the Ministry of Industry and Information Technology stated that it is making forward-looking arrangements for artificial intelligence, Web3.0 Advanced computing, 6G In the future, industries will develop new competitiveness on new tracks.   Central enterprises have established nearly 500 The home focus is mainly on strategic emerging industries such as new-generation information technology and artificial intelligence. Currently, central enterprises have made outstanding achievements in deploying into strategic emerging industries, most recently 5 The average annual growth rate of investment in strategic emerging industries exceeds 20% .    Meanwhile, since the beginning of this year, the concept of China Special Economic Zone (SEZ) valuation has been hot, with central enterprise valuations rapidly returning to normal.   Why does the state strongly encourage central enterprises to develop strategic emerging industries?    In the context of exploring the establishment of a Sino-foreign joint venture valuation model, how can the layout of strategic emerging industries positively impact the valuation of central enterprises? Which emerging industry tracks are expected to be the first to embrace development opportunities?    Frost & Sullivan Frost & Sullivan Lu Jing, Partner and Managing Director of Frost & Sullivan's Greater China Region, was interviewed by Securities Daily to discuss the layout and development of strategic emerging industries.   * Click "Read the Original Article" at the end of this text to read the full report. Securities Daily Q Securities Daily Reporter: What are the advantages of central enterprises in developing strategic emerging industries?   Central enterprises possess characteristics such as high concentration, efficiency, large industrial scale, and significant influence. From the perspective of the capital market, central enterprises can assist in the national development of strategic emerging industries through two main methods. Firstly, central enterprises can improve the rapid layout of strategic emerging industries through mergers and reorganizations. By merging and reorganizing, they can accelerate the establishment of leading enterprises in emerging industries, thereby increasing industrial concentration and more effectively creating a complete industrial development environment. Secondly, central enterprises can also play a role in financing, raising funds for the development of strategic emerging industries through multiple channels such as issuing stocks or bonds, providing strong financial support for central enterprises to accelerate the development of strategic emerging industries. Overall, state-owned assets and central enterprises can concentrate funds and personnel to help form large-scale industrial clusters, thereby accelerating the overall layout of industries and improving the development environment. Therefore, it is of great significance that the state is currently strongly encouraging central enterprises to vigorously develop strategic emerging industries. Q Securities Daily Reporter: In the context of exploring the establishment of a Sino-Tibetan economic integration assessment, what positive role does the layout of strategic emerging industries play in enhancing the valuation of central enterprises? The Sino-Tsinghua Enterprise Evaluation (STE) can effectively address the reality that state-owned enterprises have been undervalued for a long time. Unlike traditional valuation systems, the STE system reduces its focus on the profitability of enterprises themselves and places more emphasis on improving the efficiency of profitability. State-owned assets enterprises are vigorously deploying in strategic emerging industries. With the continuous catalytic promotion of policies, these emerging industries show obvious growth potential, thereby increasing expectations for the profitability efficiency of state-owned central enterprises. This will have a positive effect on enhancing the valuation of central enterprises. By raising the valuation level of central enterprises, more market funds are attracted into them, providing financial support for the development of central enterprises themselves. Central enterprises then feed back and assist in the development of emerging industries, thus forming a virtuous development cycle. Q Securities Daily Reporter: According to the State-owned Assets Supervision and Administration Commission (SASAC), a package of policies to support the development of strategic emerging industries by central enterprises will be introduced. Against this backdrop, which emerging industry tracks are expected to be the first to embrace development opportunities?   State-owned Assets Supervision and Administration Commission 2 month and 5 Since [month], several policies have been introduced to promote the development of emerging industries. Against this policy backdrop, industries closely related to national strategies, such as integrated circuits, artificial intelligence, and information technology, will attract more market capital inflows, thereby accelerating the industrial development layout. Especially, digital technology industries are set to lead the way in embracing new development opportunities. Since digital technology industries can effectively boost the efficient development of other industries, they act as a catalyst for industrial growth. For instance, traditional industries can significantly enhance their analytical and computational capabilities during the equipment R&D process with the superposition and empowerment of new-generation information technology, thereby accelerating R&D innovation efficiency. At the same time, related technologies can also improve the collection and analysis of massive industrial data, promoting quality improvement, efficiency enhancement, and cost reduction in related manufacturing processes. Therefore, digital technology industries, which can help other emerging industries and act as a catalyst, are set to quickly deploy first under policy promotion, attracting development opportunities. * This interview was published in Securities Daily.   The reporter is Xing Meng, and the original title was 'Continuously Increasing Investment in Strategic Emerging Industries Boosting the Accelerated Return of Central Enterprises' Overall Valuation    .

BioCon China Expo 2023 6 month 19 day -21 Day, lasting for three days BioCon China Expo 2023 The 10th International Biopharmaceutical Conference and Exhibition was successfully held at the Hangzhou International Expo Center. This conference brought together   10,000+ Industry peers gather in Hangzhou,    BioCon Expo The total exhibition area has been expanded to 20000 On a scale of ㎡, gathering 200 High-quality exhibitors and featured exhibits from Yuji. Several academicians and authorities PI Lead, 200 The remaining speakers are heavyweight guest representatives from government regulatory agencies, clinical, research, and industry sectors, who have contributed to 15 The remaining in-depth discussion forum covers 350+ Dry goods topic, jointly discussing cutting-edge innovation trends in the biopharmaceutical industry; opening ceremony and BioCon Awards The exclusive, authoritative event includes an awarding ceremony, dinner, guided tours for groups, brainstorming sessions, and interactive social games on site.   Frost & Sullivan Frost & Sullivan, Frost & Sullivan, hereinafter referred to as BioCon Awards The strategic partner of the awarding ceremony, in conjunction with the organizers, jointly released the 'Biopharmaceutical Enterprise Excellence Awards for 2019' and the 'Biotechnology Innovator of the Year with the Highest Investment Value'. Mao Hua, Partner and Managing Director of Frost & Sullivan Greater China, was invited to attend the main forum of the conference and serve as the moderator for the roundtable discussion.   Roundtable Forum At the meeting, Mao Hua served as the host of the roundtable forum, alongside Guo Xinjun, Senior Vice President of Fosun Pharma, and the founder of Yino MicroMedicine. CEO Chairman and CEO Zhou Guoying, Hopewell Therapeutics CSO , Editas Medicine front VP Kate Zhang Gene Therapy Company Exegenesis Bio Founders, Chairman and CEO Wu Zhenhua, together, focused on the inevitable path for domestic biotech products to go global, and discussed how to strategize and make early arrangements. Partner and Managing Director, Greater China, Frost & Sullivan fattening Mao Hua said, biotechnology   Enterprises need to conduct thorough research on market capacity and related data in overseas regions, choose an outbound model and region based on their own circumstances, and implement localization execution strategies; do a good job in product positioning analysis and market analysis, make strategic layouts for the entire product lifecycle, adhere to long-termism and a global perspective, and build a systematic and international business system. Fuhong Hanlin Senior Vice President   Guo Xinzhen Founder of Yino MicroMedicine, CEO Chairman and Director   Zhou Guoying Hopewell Therapeutics CSO , Editas Medicine front VP Kate Zhang Gene Therapy Company Exegenesis Bio Founder, Chairman, CEO   Wu Zhenhua   BioCon Awards Award Ceremony   "BioCon Awards "yes BioCon China Expo An authoritative biomedical award created by the organizing committee. This year, BioCon Awards Comprehensive upgrade, covering a total of seven major categories including upstream and downstream enterprises in the biopharmaceutical industry chain / organization / Individuals strive to establish an authoritative industry award that covers the entire lifecycle of the industry, selecting annual leaders at every stage, commending industry pioneers, and creating an industry atmosphere and environment that is proactive, innovative, and forward-looking in the biopharmaceutical industry.   Frost & Sullivan as BioCon Awards The strategic partner of the award ceremony, in collaboration with the organizers, released the 'Annual Outstanding Achievements Star in Biopharmaceutical Enterprises' list and the 'Annual Most Investment-Valuable Biotechnology Rising Star' list.   Outstanding Annual Outstanding Achievements Star in Biopharmaceutical Enterprises   Presenting Guests:   Shao Yuanchang, former First-Class Inspector of the Zhejiang Provincial Drug Administration and President of the Zhejiang Pharmaceutical Association   Award-winning organization: Aimeijie Vaccines Co., Ltd. Baitai Biopharmaceutical Co., Ltd. Baida Pharmaceutical Co., Ltd. Shanghai Fuhong Hanlin Biotechnology Co., Ltd.   limitless The Most Investment-worthy Biotech Rising Star of the Year   Presenting Guests:   Tang Dajie, Chairman of Shenzhen Qianhai Qinzhi International Capital Management Co., Ltd.   Award-winning organization: Wuhan Ruijian Medical Technology Co., Ltd. Beijing Zhidao Biotechnology Co., Ltd. Shanghai Huayao Tai Biopharmaceutical Co., Ltd. Korontar Biopharmaceutical Co., Ltd. Nanjing Reindeer Biotechnology Co., Ltd. Saiyuan Biotechnology (Hangzhou) Co., Ltd. Shanghai Bangyao Biotechnology Co., Ltd. Shenzhen Yino Micro Medicine Technology Co., Ltd. Zhejiang Haichang Biomedical Technology Co., Ltd. Beijing Chengnuo Medical Technology Co., Ltd.

6 month 17 day, Live Report The online salon event 'Face-to-Face with Big Names', hosted by Big Data, was live-streamed simultaneously on more than a dozen channels. Frost & Sullivan Frost & Sullivan Partner and Managing Director of Frost & Sullivan Greater China Region, Co-founder of LeadLeo CEO Mr. Yang Xiaocheng was invited to the live broadcast room to have a wonderful live dialogue with Mr. Wan Yong, the Executive President of TradeGo. The content shared covers the significance of in-depth research on global companies planning to go public or already listed, empowering capital operations and corporate development, as well as addressing various aspects of company development. Mr. Yang Xiaocheng, combining years of in-depth industry research experience, has analyzed various industry research issues that enterprises may encounter during the listing process in a simple and profound manner.   01   Frost & Sullivan: a global leader in growth consulting, A leading enterprise in the field of domestic investment strategy consulting Frost & Sullivan Frost & Sullivan Frost & Sullivan, commonly referred to as 'Frost & Sullivan&rdquo), is a global leader in enterprise growth consulting. 1961 Founded in Wall Street, USA, globally 62 years of history. Globally owned 45 An office, approximately 3,000 Famous consulting advisors and analysts provide comprehensive investment, financing, and various other professional consulting services for enterprises, including due diligence services, valuation services, assessment services, strategic consulting, management consulting, planning consulting, technical consulting, financial consulting, industry consulting, etc. Covering sectors such as pharmaceuticals and healthcare services, consumer services, transportation and travel, internet technology, retail, aerospace, financial services, etc. 20 Large industries. From a global perspective, we help clients accelerate their business growth, enabling them to achieve growth, technological innovation, and leading benchmarks within their industry. Frost & Sullivan is also an absolute leader in providing industry advisory services for corporate listings in Hong Kong for the past three years. IPO listing The average market share exceeds 55% , and participated in more than 200 Set sail for overseas IPO listing . Frost & Sullivan is located in 1998 Entering the Chinese market in 2018, it has helped nearly a thousand companies successfully list on the Hong Kong and overseas stock exchanges, making it a leading enterprise in the field of investment strategy consulting in China. 2014 till 2022 In the year, Frost & Sullivan has maintained its leading position as the market research advisor with the largest share in the Chinese companies going public in Hong Kong and overseas for consecutive years; moreover, in recent years, Frost & Sullivan reports have also been widely cited by industry leaders. A Prospectus documents, primary market research reports, and other capital market disclosure documents of listed companies such as stocks and Sci-Tech Innovation Board companies. In the past eight years, we have served more than 1,000 Home, occupies various industries going overseas IPO listing The absolute leadership position of Market Industry Advisor. Frost & Sullivan has set up offices in Greater China. 7 The offices are located in Beijing, Shanghai, Hong Kong, Shenzhen, Nanjing, Chengdu, and Taipei.   02   Yang Xiaocheng: Over fifteen years of capital market service experience,   Led and participated in the listing, acquisition, and merger projects of dozens of domestic and overseas enterprises   Mr. Yang Xiaocheng    Partner and Managing Director of Frost & Sullivan, Co-founder and CEO Mr. Yang has over fifteen years of experience in capital market services, responsible for the international capital market department of Frost & Sullivan, providing clients with investment and financing consulting, valuation, financial advisory and other services. Mr. Yang has led and participated in the listing and acquisition mergers and acquisitions of dozens of domestic and international companies. Before joining Frost & Sullivan, Mr. Yang worked at BOC International Securities Co., Ltd. and Deloitte Touche Tohmatsu.   03   Three Core Issues in Industry Research     Who are you?     Entrepreneurs and bosses may have misunderstandings about the positioning of their companies. The perspective from within a company is different from that of investors, leading to cognitive gaps due to different identities. This is commonly referred to as the 'founder blind spot.' Founders often view the overall situation of the company from an internal perspective through product and technology, while outsiders see it very differently. Therefore, what we mean by who you are is not just who you think you are, but also letting the outside world know who you are and knowing for yourself who you want to become in the future.   Where are you from? Simply put, it refers to the current state of the company. For startups, what kind of technology does it possess, what products are available, what is being sold, and what position does the company currently hold in the market, whether it is in an emerging market or a relatively traditional industry? If in a traditional industry, does the company have any disruptive or significant innovations that could change the current state of the industry, thereby empowering traditional industry technologies? Many companies have great imagination in their business and products, but they fail to convey this well when introducing themselves, sometimes even having a negative impact, ultimately resulting in unsatisfactory company valuation and recognition.   Where are you going? Speaking of the future, whether there will be major upheavals and transformations in the industry, especially in the capital market IPO listing From a market perspective, it is even more important to talk about the future. The valuation of a company not only reflects its current net profit but also reflects different views on the future of the industry. If one is optimistic about the company's future, the current valuation will be higher, and valuation standards such as price-to-earnings ratio or price-to-sales ratio may also increase.   04   Application scenarios of business research     1 Internal Insights of Enterprises   Know yourself and your enemy, and you can fight a hundred battles and win a hundred percent. Through in-depth analysis, from comprehensively understanding the industry situation, clarifying one's own positioning, to formulating development strategies, this approach helps enterprises gain insights into their internal conditions, thereby providing comprehensive and strong support for their future development.   Source: Frost & Sullivan   Classical Case Sharing:    Frost & Sullivan assisted a X A technology company focused on optical emitters, it has identified the right track to achieve overtaking on a curve, achieving a double harvest in both business and valuation. During its five years of service, from initial financing to company development, and to listing on the Sci-tech Innovation Board and entering the capital market, the company has achieved a sixfold growth.     2 ) IPO listing and capital operation   ① In-depth industry research support IPO listing Multiple aspects of the process, including prospectus writing and Q&A, fundraising report writing, experimental data verification, and ESG And annual report updates, etc., to help the company tell a good investment story.   Source: Frost & Sullivan   ② Through four major modules: pre-listing leading-edge communication, listing prospectuses and industry reports, post-listing inquiries and response materials, and company valuation roadshow materials, we provide one-stop research services for the company from pre-listing to post-listing.   Source: Frost & Sullivan   ③ Frequently Asked Questions about Industry-Related Queries that May Be Encountered During the Listing Process:   （ 1 Regarding market size issues: explain how the boundaries of the company's market are defined, and what specific factors are considered; what methods and logic are used for market size estimation, and whether it is scientific and reasonable. （ 2 Regarding market share: What are the major enterprises in the industry, what is their operating revenue and market share for similar businesses; are the market data of other competitors fair and reliable? （ 3 Regarding comparable company issues: What technical advantages does the company have compared to its competitors, and how is this quantitatively analyzed? Disclose the market competition situation in different downstream application fields. （ 4 Regarding the issue of leading position: Regarding expressions such as 'the first in China' and 'No.1 in China', please provide relevant evidence; considering the background of the honors and awards received, patents, etc., analyze whether this is conducive to investors' understanding of the company's technological advancement.   Source: Frost & Sullivan   Classical Case Study Sharing:    Through the product sales forecast analysis method of biopharmaceutical companies under research and development, based on in-depth industry research and enterprise surveys, a model is built for prediction. Variables are verified, adjusted, and the prediction results are controlled within an acceptable reasonable error range.   Source: Frost & Sullivan     3 ) Confirmation of the enterprise's market position   In-depth industry research supports the confirmation of a company's market position, including recognition and reputation, brand image, influence, compliance, and more.   Source: Frost & Sullivan Some of Frost & Sullivan's service cases: such as Peiji Laohongpu, Xicha, and China Feihai.   05   Wonderful Q&A   1 How is a new industry defined, and what are the differences between new consumption and traditional consumption?   Yang Xiaocheng: New consumption is a broad concept, and the difficulty does not lie in its definition. Take new-style tea drinks for example; milk tea can currently be defined as traditional consumption. However, in terms of innovation, it is now referred to as Chinese new tea drinks, Chinese new consumption, Chinese new chains, etc. These are just names; they are not difficult to come up with, and we can brainstorm them at will. But the difficulty lies in how we make the public accept it. This acceptance needs to be supported and defined by authority, methodology, models, etc., to distinguish between new and traditional.   2 , AIGC Impact on industry research?     Yang Xiaocheng    :   AIGC Industry research is not a shock, but rather a significant empowerment. AI There are currently two major issues in creation that need to be addressed: one is AI It is not responsible for the company's data, models, algorithms, content, etc. Secondly, the underlying content and algorithms are not clean enough, and the underlying data is rather messy. When searching for the same thing, content creators may agree with each other, but which content is truly worth citing? There is currently no good solution to this problem. LeadLeo is currently developing some knowledge-based data labels in this area, including standards and definitions for which content can be traced back, cited, and adopted, thereby empowering industry research; AIGC The future will be a trend of integration and collaboration with humans.   3 , when a company undertakes multiple     When a business can be attributed to several sub-industries, how are its industry attributes assessed?    Yang Xiaocheng    :   The industries to which one belongs each have their own advantages and disadvantages. The first type is smaller-scale ones, where we need to analyze the company's proportion in different market segments or industry types. If a company has a high proportion of a certain main business, then we will focus on that business and use it as a gateway to other market segments. For example, automotive chips may be found to have applications in agricultural machinery or construction equipment, as well as other future market prospects. The second type is group companies, such as state-owned enterprises and central enterprises, which have multiple business lines. At this time, we will select and highlight those businesses with more development prospects, combined with existing traditional but stable cash flow-providing businesses, one for the present and one for the future, to form an integrated investment story.   4 What relevant suggestions are there from an industry research perspective for companies planning to list or those that have already listed or are already a listed company?    Yang Xiaocheng    :   Companies that have already filed for listing or are listed companies cannot be changed, and their current situation can only be highlighted through live broadcasts or roadshows. For companies planning to file for listing, the operational aspect is relatively higher. First, we can invest more manpower in sorting out the company's business lines in the early stages, thereby creating a better-positioned investment story. Second, we can test the waters by conducting online and offline roadshows to see how market investors react. For example, if you are currently talking about a new consumption concept and the market doesn't recognize it yet, the feedback might be average. Then we have the opportunity to adjust; if the feedback is good, we can continue to strengthen this aspect. Moreover, we can also test the recognition level in the secondary market or preheat it ahead of time, because there is currently some pressure on Hong Kong stock market issuance. Does the company have a certain level of popularity in the market, or can it make the market more aware of its situation? If the company has a certain level of popularity, it may receive more attention and is more likely to obtain funds from the market, which is conducive to the company's smooth issuance.

2023 International Conference on Medical Device Supply Chain 2023 year 6 month 15 - 17 On 2023 (The Third) International Conference on Medical Device Supply Chain was successfully held in Weihai. The conference, themed 'Breaking Through Barriers for Sustainable Growth', focuses on the pain points and difficulties in the development of global medical device supply chains, discusses the future development of the medical device industry, aims to break through bottlenecks and eliminate barriers, and promotes high-quality development of the medical device supply chain during the 14th Five-Year Plan period. Frost & Sullivan Frost & Sullivan Guo Jing, Senior Consulting Director for Healthcare in Greater China at Frost & Sullivan (hereinafter referred to as 'Frost & Sullivan'), was invited to attend the conference.   as for   The Background and Trends of Chinese Medical Devices Going Global   Give a speech   . Senior Healthcare Industry Consultant, Frost & Sullivan Greater China Guo Jing According to a study by Frost & Sullivan,   2022 The global overall medical device market size is larger than that of China. 4 times, China    The overseas market for medical devices has a very broad potential.    Compared with the leading global players in medical devices, Chinese medical device companies have a smaller proportion of overseas sales.    Global leading medical device companies have a much larger proportion of overseas sales than domestic players, abroad Top 5 Medical device enterprise 2022 Annual income exceeds 50% From overseas, and China Top 5 In addition to Jiuan Medical Devices, the products of other medical device companies are mainly sold domestically.   Guo Jing stated that the Chinese medical device industry is squeezed by three major pressures: in-hospital cost control policies, normalized centralized procurement, and homogeneous competition. Coupled with the relatively small proportion of overseas sales by Chinese medical device companies, it has become an inevitable trend for local enterprises to explore strategies for going global in order to seek profit growth points.   2022 In 2019, China's exported medical device products mainly consisted of low-value consumables and mid- to low-end medical equipment.    Guo Jing pointed out that driven by market demand and favorable policies, the export-oriented 'Belt and Road' region will become an effective way for domestic brands to initiate international development. Driven by several favorable policies in China, the R&D capabilities of medical device enterprises have continued to improve, and their overseas competitiveness has further strengthened. However, enterprises still face three major tests when going global: policy environment, sales model, and technical recognition.   Guo Jing believes that, under the trend of domestic brands going global, five key areas—technological innovation, adaptability and compliance, localized marketing, stable supply chains, and comprehensive support—will become the main focus for local enterprises in pursuing both 'brand value' and 'profit growth'. About Frost & Sullivan's Healthcare Practice   The Healthcare Practice of Frost & Sullivan has professional analytical capabilities and extensive project experience in the life sciences field. Leveraging Frost & Sullivan's global think tank resources and cross-industry business development platform in Greater China, Frost & Sullivan Healthcare has unique core advantages in healthcare industry investment and financing services. Frost & Sullivan Healthcare has a wide range of corporate clients in China and in the past 20 In the year, a vast customer network was established, and a wealth of project experience in various medical sub-fields was accumulated. Project types include Knowledge Center projects (in-depth content and promotional activities). Pre-IPO financing project DCF model Valuation, Business Plan Services), IPO listing We provide listed projects (industry consulting, clinical audits, fundraising and investment writing), market research, market value management, and strategic consulting. We also cooperate with well-known domestic and international information platforms and investment and financing institutions, offering one-stop solutions for enterprises in specialized fields such as pharmaceuticals and medical devices, which has attracted widespread attention from investors.

6 month 13 day -15 On 25 The 8th Shanghai International Biotechnology and Medicine Symposium BIO-FORUM 2023 held in Shanghai   The conference brought together approximately 200 Well-known domestic and international scholars in biotechnology and medicine, as well as senior corporate executives,   Exchange, discussion, and promotion will be carried out on new technologies, new developments, new policies in professional fields such as disruptive technologies, nucleic acid drugs, synthetic biology, new vaccines, cell and gene therapy, management of human genetic resources and biosafety, biomedical engineering, as well as the transformation of international innovative technological achievements.   Frost & Sullivan Frost & Sullivan Partner and Managing Director of Frost & Sullivan Greater China Region, Co-founder of LeadLeo CEO Yang Xiaocheng was invited to attend the Youth Forum of this conference and delivered a report on the research report of the synthetic biology industry   From 'investigating things to acquire knowledge' to 'creating things to acquire knowledge'   "The keynote speech." Partner and Managing Director of Frost & Sullivan Greater China, Co-founder of LeadLeo CEO Yang Xiaocheng According to Yang Xiaocheng, synthetic biology (Synthetic Biology) It is an interdisciplinary field that refers to the targeted design, modification, or creation of organisms with unnatural functions under the guidance of engineering concepts, known as 'artificial life'. Synthetic biotechnology can directionally transform biological systems into efficient cellular systems for large-scale production and processing. The main tools in synthetic biology include DNA sequencing technology, DNA Assembly technology, intracellular logic gates, genome editing tools, and riboswitches can be used to construct two types of synthetic biology systems: 1. Design and construct new biological components, modules, and systems; 2. Optimize and transform existing natural biological systems.   As a revolutionary and progressive technology, synthetic biology is environmentally friendly throughout the entire process, helping to reduce the dependence on non-renewable energy in various application fields.   Yang Xiaocheng pointed out, 'Design - Construct - testing - Learning ”loop (DBTL) It is the core R&D model of synthetic biology   It can effectively screen and optimize the required biosynthetic devices and system functions. The above model is realized with mainstream technologies such as gene editing technology, and the future technological development direction will also transition towards low cost, automation, and integration.   Yang Xiaocheng stated that the dividends brought about by the continuous development of synthetic biology technology are gradually being reflected at the market level. projected 2027 The overall market volume in 2023 will reach nearly $40 billion: With the increase in application scenarios and technological improvements, the synthetic biology industry is rapidly expanding.   . 2022 The global synthetic biology market size is 139.8 billions, expected to 2027 The global market scale reached 387.3 billions. Among them, healthcare will become the largest sub-market, 2027 The annual market scale accounts for 26.6% .   The synthetic biology market has enormous potential, with high growth prospects reflected in multiple fields.   Among them, food and beverages, as well as agriculture, are expected to be the fastest-growing sectors in the future. Animal and plant selective breeding, DTC Gene testing, microbial-based beauty products, etc., bring broad prospects for application.   From the perspective of the industrial chain, Yang Xiaocheng pointed out that the synthetic biology industry chain consists of a tool layer, software and hardware layers, and an application layer. The industrial ecosystem covers a vast range of areas, with diverse implementation directions for different technologies and industries. Enterprises are developing towards full integration of the entire industrial chain, aiming to reduce business risks and enhance competitiveness by connecting all parts of the chain. In terms of the upstream part of the industrial chain, gene editing involves inserting, deleting, modifying, or replacing specific locations in the genome of an organism. DNA Gene editing relies on genetically engineered nucleases, also known as 'molecular scissors'. Gene editing technology has come from 1996 First-generation gene-editing technology of the year ZFN Designed to go 2012 year CRISPR Technology has emerged and gone through three iterations. CRISPR/Cas9 technology The editing capability has made a significant leap.   In the midstream of the industrial chain, there are mainly platform-based enterprises responsible for organism construction and automation. By developing underlying software technology, hardware equipment, and corresponding solutions for synthetic biology, they form the foundation for the development of synthetic biology.   As the first stock in synthetic biology in China, Kaisai Biotech holds a leading position in both research and development and commercialization.   In the downstream of the industrial chain, synthetic biology is widely applied in the healthcare field, including innovative treatment therapies (cell immunotherapy, RNA Drug, microbiome therapy, gene editing-related applications), in vitro testing, medical consumables, drug ingredient production, pharmaceutical enzymes, and many other directions. Synthetic biology has been widely applied at the molecular, cellular, ecological, and organ xenotransplantation levels. By designing entirely new intracellular metabolic pathways, pharmaceutical products can be synthesized using cheap sugars and other raw materials through microbial cells. Moreover, suitable therapeutic gene circuits can be artificially designed and constructed according to different disease types and pathogenic mechanisms, and implanted into the human body with the help of vectors to achieve therapeutic goals. With the deep integration brought about by synthetic biology technology, it will bring tremendous imagination space and market opportunities to the field of healthcare.   Immediately afterwards, Yang Xiaocheng analyzed from the perspective of the investment and financing market. He believes that 2022 In the year, investment and financing in synthetic biology dropped significantly, returning to commercial rationality.    2022 In [year], global synthetic biology raised funds 103 billion US dollars, than 2021 Decrease in annual value 115 billion dollars. 2023 Raising funds in the first quarter of the year 28 Billions of dollars, the lowest amount in the same period over the past three years, showing an overall downward trend. Investment is moving towards rationality and precision. On the other hand, with the development of synthetic biology, more and more early experimental results are becoming products that are entering the market. 2023 In the first quarter of 2021, the amount of investment and financing in the application field reached 18 billions of US dollars, accounting for the full quarter 64.3% The application areas are still dominated by the health and pharmaceutical sector, with the materials sector ranking second. At the same time, sectors such as drugs, diagnostics, bioenergy, and consumer goods have a clear advantage in raising venture capital and are beginning to occupy market positions.   Regarding economic impact, Yang Xiaocheng said, in the future 10 - 20 In the year, synthetic biology is expected to create approximately 2 - 4 Trillion-dollar direct economic impact. Forecast 2030 - 2040 In [year], synthetic biology will have an annual economic impact of 1.8 - 3.6 trillion dollars, to 2040 - 2050 In [year], the economic impact further expanded to 3.0 - 5.1 trillion dollars. Among the many sub-sectors, the most direct impact is seen in life sciences and people-oriented fields. Life sciences are the area where scientific research and development have made the most progress, with a clear chain from research and development to application. The market generally accepts and welcomes technological innovation, making the implementation of synthetic biology applications more predictable. In addition to the life sciences, applications are also very widespread in fields such as agriculture, aquaculture, and food that are closely related to human life, reaching 36% .   So, what is the current state of the overall market competition landscape? Taking product-based companies as an example, Yang Xiaocheng believes,   Synthetic biology is widely applied in the field of healthcare, including cell immunotherapy. RNA Drug, microbiota therapy, gene editing-related applications, in vitro testing, medical consumables, drug ingredient production, pharmaceutical enzymes, etc.     For example, utilize mRNA Technologies include rapid artificial synthesis of vaccines, the use of gene editing technology to treat genetic diseases, and the modification of microorganisms to produce medical consumables and pharmaceutical components.   Currently, synthetic biology companies in the medical field are mainly international enterprises. ,   Rich in listed and reserve products Moderna Therapeutics Possess super 40 The product pipeline is far ahead. Chinese companies such as Legend Biotech and Synobiogen are developing products related to rare diseases and solid tumors using gene editing technology, cell therapy, etc., such as 2020 China's first independently developed cell therapy LCAR-B38MCAR-T to the United States FDA Submit the listing application.   With the innovation and application of synthetic biology technology, there is hope that it will further assist in the prevention, diagnosis, and treatment of diseases such as tumors, malaria, and strain infections.   Finally, Yang Xiaocheng pointed out that the synthetic biology industry currently presents two major development trends.   First, the development of carbon neutrality catalytic industries.   The government report has repeatedly mentioned the goals of "carbon neutrality" and "carbon peak", quantified carbon emission reduction targets, and proposed to 2025 Realized GDP per unit of GDP in the year GDP Carbon dioxide emissions ratio 2020 Decrease in annual value 18% goals. Synthetic biology manufacturing is a promising green production method. Its application in the field of chemical production by synthetic organisms demonstrates environmental protection and cost advantages. Compared to traditional chemical production processes, carbon emissions have been reduced. 75%-100% Among them, produced by Huaheng Biology L- Alanine even achieves zero emissions, making it environmentally friendly and in line with the development purpose of 'carbon neutrality'. At the same time, policies such as carbon taxes for carbon neutrality are gradually being implemented, which will further widen the cost advantage of biomanufacturing over traditional processes. The manufacturing industry related to synthetic biology will also embrace important development opportunities.   Second, artificial intelligence is gradually being applied in synthetic biology to help improve R&D efficiency. While enhancing R&D possibilities, it may also reduce R&D costs.   Currently, artificial intelligence has been widely applied in fields such as component engineering, genetic circuits, metabolic engineering, and genome engineering, improving work efficiency in various stages, significantly reducing costs, successfully shortening R&D cycles, and expanding R&D possibilities. Deep Mind of Alpha Fold The platform can now predict protein structure up to 2 Yi, from 100 Tens of millions of species. In the future, scientists are expected to design enzymes with higher catalytic efficiency or position-specific catalytic functions that do not exist in nature, and further develop more efficient metabolic pathways or synthesize substances that cannot be biosynthesized in nature. However, the application of artificial intelligence in synthetic biology is still in its infancy, and there are limitations and challenges in data, algorithms, evaluation indicators, etc., which require further development. Recommended Reading   "The 2023 China Synthetic Biology Industry Research Report 2019

In 2023, the world enters a new period of turmoil and transformation. The profound changes unseen in a century are accelerating, posing significant uncertainties and challenges to China's economy. How can it effectively respond to these global economic slowdowns, live up to expectations, and drive global economic recovery? Standing at a critical juncture connecting the '14th Five-Year Plan' with the long-term vision of 2035, and bridging the past and the future, what new growth points does the Chinese economy have in its journey towards high-quality development? How can the market sustainably boost endogenous dynamics and stimulate the driving force for technological innovation? How can enterprises seize new opportunities in new markets and tracks, finding their foothold? How will new investments create an innovation network and ecosystem that aggregates multiple dimensions such as industry, academia, research, and investment, becoming the best partner for enterprise development?   Based on this, the 2nd New Investment Expo 2023 and the 17th Frost & Sullivan Global Growth, Innovation and Leadership Summit (hereinafter referred to as the 'Frost & Sullivan New Investment Conference' or the 'Conference') will be held again on September 27-28, 2023, at the 'World Salon' in Shanghai. With the theme of 'Pooling the Forces of the Galaxy to Draw an Infinite Blueprint' and the vision of 'Building a Comprehensive Investment Management System to Seek Certainty in the New Era', the Conference is dedicated to presenting an international value audio-visual feast that deeply empowers practitioners of 'New Investment'. The Conference will work with global industry leaders, innovative forces, and growth disruptors to interpret international situations, new opportunities for industrial development, explore new paths for the deep integration of the real economy and the digital economy, diagnose forward-looking investment trends, stimulate new momentum for the symbiotic prosperity of industrial value and capital energy, set sail into the new era, and strive towards great development!   Host City: China · Shanghai Venue: September 27 - 28, 2023 Conference scale: 3,000 people+ Conference format: Offline + Online Venue of the conference: Shanghai Pudong Shangri-La Hotel Sponsor: Frost & Sullivan Co-sponsors: LeadLeo Strategic Partners: Boao Forum for Asia Global Health Forum Conference, China Biomedical Industry Chain Innovation and Transformation Alliance (CBIITA), Shanghai Biomedical Science and Technology Development Center, EY, JD Health, Jingtian Gongcheng, China Financial Information Center, Roadshow China, Titanium Media, TradeGo, New Catering Chain, Whale Platform Supported Units: Shanghai New Businessmen's Federation   1 Opening Ceremony 1 plenary session 7 Sub-forums 1 expo 1 awarding dinner All-day corporate roadshow Rich and exciting content!   01 Highlights of the conference Global Vision and Capital Value The conference innovatively integrated a global perspective, macroscopic viewpoint, and industry agglomeration effects, demonstrating the Frost & Sullivan Group's profound insights into primary and secondary markets, and exploring the best solutions for corporate growth in the new era. Responsible persons from regulatory authorities, representatives from local government departments, Hong Kong Exchanges and Clearing Limited (HKEX), Shanghai Stock Exchange/Shenzhen Stock Exchange/Beijing Stock Exchange (SSE), and major overseas exchanges, representatives of IPO intermediaries, investment institutions, industry experts and scholars from the Frost & Sullivan Global Expert Database, and representatives of leading domestic and international enterprises gathered together to engage in a lively exchange on key areas of global concern and with Chinese representativeness. It is a rare intellectual feast and audio-visual spectacle!   Star project roadshow In the corporate roadshow session, we will invite companies that have made breakthroughs in a certain field and are seeking cooperation or investment opportunities to participate. This session will be an excellent platform for listed companies and most of the exhibitors to showcase their business value and find partners. It will also help investment institutions at different stages of financing and investment to accurately connect with enterprises, empowering investment implementation, innovation leapfrogging, industrial transformation and upgrading, and high-quality development.   High-end social dinner On the evening of the first day of the conference, a GIL awarding dinner will be arranged. All keynote speakers and special invitees will be invited to attend the dinner. In a relaxed and cheerful atmosphere, sharing drinks and chatting with global business leaders, industry experts, investment gurus, and tech pioneers may spark unique ideas!   Industry-specific Luncheon/Dinner On the following day, lunchtime and evening sessions will be arranged for multiple industry-specific luncheons. All keynote speakers and special invitees for the day will be invited to attend these luncheons. In a relaxed and comfortable atmosphere, participants can engage in in-depth exchanges and discussions with industry leaders, discover new opportunities, and facilitate win-win cooperation.   02 Conference Agenda September 26 18:30 - 20:30 Dinner for VIPs and Partners (Limited Seats)   September 27 09:00 - 12:00 Opening Ceremony and General Assembly 12:00 - 13:30 VIP Business Luncheon 13:30 - 16:00 Sub-forum: New Investments 13:30 - 17:30 Plenary Session: Digital Economy and Industrial Integration: Industry-wide Transformation Accelerated by AI 17:30 - 18:00 barbecue party 18:00 - 21:00 GIL Awards Banquet and Frost & Sullivan's 25th Anniversary Celebration in Greater China (Limited Seats)   September 28 09:00 - 12:00 Sub-forum: High-quality Development of Listed Companies 09:00 - 12:00 Sub-forum: Biotech Investment (Morning Session) 09:00 - 12:00 Sub-forum: New Energy (Morning Session) 09:00 - 12:00 Corporate Roadshow (Morning Session) / Government Investment Promotion Conference 12:00 - 13:30 Special Lunch Event (Limited Seats) 13:30 - 16:30 Sub-forum: Biotech Investment (Afternoon Session) 13:30 - 18:00 Sub-forum: 2023 China Catering New Consumption and Industrial Investment Summit Forum (Afternoon Session) 13:30 - 16:30 Sub-forum: New Energy (Afternoon Session) 13:30 - 16:30 Sub-forum: High-end Manufacturing 13:30 - 16:30 Sub-forum: Innovation and Entrepreneurship 13:30 - 16:30 Corporate Roadshow (Afternoon Session)   03 About the New Investment Conference The New Investment Expo (NIE) originated from the Growth, Innovation and Leadership Summit established by Frost & Sullivan (Frost & Sullivan).   The Frost & Sullivan Summit is held in over 20 countries and regions around the world and has a history of nearly 30 years. It attracts a large number of Fortune Global 1000 companies, top domestic and international financial institutions, and other leading enterprises to participate deeply. It helps them identify opportunities, innovate continuously, accelerate growth, and gain a leading position in an increasingly complex and changing world.   Since its inception in China in 2008, the Frost & Sullivan Summit has been held for sixteen sessions, with a cumulative attendance of over 8,000 people.   Today, the Frost & Sullivan Summit has become an important platform for outstanding domestic enterprises, the investment community, and regulatory authorities to exchange successful experiences and jointly explore development directions. It is also a vital window through which the world understands China's most cutting-edge development trends.   04 Review of the Previous Session   The conference brought together 1,000 The remaining seats come from leading enterprises across various industries, a large number of outstanding innovation projects, representatives from governments, investment institutions, financial institutions focusing on industrial development, as well as universities and scientific research experts.   The participating enterprises cover industries such as biotechnology and big health, TMT, intelligent manufacturing, metaverse, consumer goods, insurance, education, and finance.   In terms of the number of companies, listed companies account for about 19%, financing projects for about 31%, and investment institutions for about 34%. Among them, participants at the founder/executive chairman/CEO/general manager level account for about 35%, and those at the vice president/director level account for about 45%.   Previous Conference Booth Effectiveness (Partial)   Keynote Speakers (Partial List) of the Previous Session Media Communication Effect of the Previous Session Total SEO Exposure super 2,518 million times   Media report PV value Over 6 billion times   Total online live streaming exposure Over 600,000 person-times   The conference adopted the live broadcast of professional platforms during roadshows and synchronized the broadcast on nearly 20 platforms including Titanium Media, China Financial Information Center's video account, Orient Fortune Choice data, Tonghuashun iFinD, Wande 3C, Tianfeng International, TradeGo, Snowball, Dalu Roadshow, Futu NiuNiu, Xingzheng International, Frost & Sullivan's video account, LeadLeo's video account, Yaolu, Meibai Medical & Health, etc. During this period, nearly a hundred high-quality enterprises made an appearance at the exhibition, presenting hundreds of roadshows to nearly a hundred investors, attracting the high attention of over 600,000 professional online and offline audiences.   05 Sign up for the conference   Conference tickets ¥3,980 per bit On the occasion of the 100-day countdown to its opening 100 free conference passes Limited-time Offer Scan the QR code or Click on the end of the article to read the original text. Sign up now

FBIF 2023 2023 year 6 month 14 - 16 Today, with the theme of "Recreating Miracles" FBIF2023 Food & Beverage Innovation Forum FBIF The Food Innovation Exhibition will be held at the Shenzhen International Convention and Exhibition Center (Bao'an).   this year FBIF Welcome to the 9 This year, the overall scale of offline forums and exhibitions has been newly upgraded. FBIF2023 cumulative 300+ Keynote speaker 900+ Exhibitors 7,000+ Industry guests attended, attracting 30,000+ Professional audiences attend conferences and exhibitions. duration 3 The forum will discuss industry trends and innovative cases from various perspectives such as dairy products, snacks, baking, beverages, alcohol, condiments, ready-made dishes, as well as industry strategies, ingredients, marketing, channels, supply chain, packaging, investment and financing. It will also feature the awarding ceremonies of two major events and over 62,000 square meters FBIF The Food Innovation Exhibition brought more innovative ideas. Frost & Sullivan Frost & Sullivan Mr. Zhang Jian, Partner and Managing Director of Frost & Sullivan's Greater China Region, was invited to attend the forum and delivered an opening speech for the 'Dairy Innovation' sub-forum, focusing on the current development status and future trends of the dairy industry track, and engaging in a discussion   New Era of Dairy Industry   . Partner and Managing Director of Frost & Sullivan Greater China Region Zhang Jian Zhang Jianjun first briefly analyzed the current development status of China's dairy market, pointing out that   Dairy products cover multiple business segments, including liquid milk such as white milk and yogurt, as well as dry dairy products such as milk powder, butter, cheese, and light cream. By covering all consumer groups across the entire product line, it is conducive to further promoting the development of the dairy market. The dairy industry has a long and complex industrial chain, covering multiple links such as feed planting and processing, dairy cow breeding, dairy farming, dairy product processing, wholesale and retail. At the same time, the development of the cold chain logistics industry has played an important role in ensuring the quality of dairy products and reducing circulation losses.   According to a study by Frost & Sullivan,   With the advent of consumption upgrading and the popularization of national health awareness, China's dairy production and retail sales have been increasing year by year. National demand has driven the continuous expansion of the dairy market scale. Public knowledge about drinking milk has gradually enriched, and drinking milk behavior has also been gradually improving.   Driven by factors such as increased disposable income among residents, diversification and high-endization of dairy products, and the development of new retail models, the consumption of dairy products and milk by Chinese residents has gradually increased, leading the dairy industry to develop rapidly on a large scale. Zhang Jianjian further added that, according to research data,   China's dairy product output 2018 year 2,687 Ten thousand tons grew to 2022 year 3,118 10,000 tons 2018 Year-end 2022 Annual average compound growth rate is nearly 4% ; Retail sales of dairy products were 2018 year 4,185 RMB 10 billion, an increase of 2022 year 6,246 RMB 10 billion 2018 Year-end 2022 The annual average compound growth rate exceeds 10% . Subsequently, Zhang Jian summarized five development trends in the Chinese dairy industry:   Trend 1:   High-end   Consumption upgrading drives different age groups of consumers to have different demands for milk powder; with the increase in per capita disposable income in China, people's pursuit of nutrition and etiquette is also constantly rising, making high-endization and category segmentation trends.   Trend 2:   Enhanced concentration   Major dairy companies in the midstream have accelerated their control over upstream farms + Self-built large-scale ranches, including leading large-scale ranches and international dairy giants, have joined forces to promote the annual per capita milk yield and milk production of dairy cows in China to reach international advanced levels.   Trend 3:   Technological progress   With the development and promotion of low-temperature liquid milk processing technology, more active protein content from natural milk can be preserved. This not only ensures a more comprehensive nutritional profile of the product but also extends its shelf life, breaking through the limitations of transportation and sales radius, which is beneficial for the national strategic layout of dairy companies.   Trend 4:   functional   Consumers have put forward more functional demands for liquid milk products, and adding professional ingredients is an inevitable path for dairy brands to meet consumers' functional needs.   Trend 5:   Leisure   With the leisureization of dairy consumption scenarios, diverse flavors have become a consumer concern; and the exploration of new flavors often comes with changes in dairy forms, evoking new consumption scenarios for consumers, not limited to breakfast snacks.   Zhang Jian pointed out that in recent years, China's dairy products have ventured into new tracks.   Dairy products, combined with coffee and baking, have become a new favorite in the industry. Instant milk coffee, novel tea drinks, etc., have also promoted market prosperity.   New tea drink brands actively cater to the health-conscious consumer trend. The growth rate of powdered ingredients used in traditional milk teas has slowed down, and they are gradually replacing them with liquid products such as milk and new processed dairy products to meet consumers' new demands.    New combinations of dairy products and various consumer goods for promotion B end and C The market is booming, and new-style tea drinks have officially launched differentiated competition. They have upgraded from traditional milk tea to more innovative ones such as cheese fruit tea, cheese tea, and milk tea, better meeting consumers' needs for tasting tea and enjoying top-quality beverages;    The use of innovative ingredients such as buffalo milk, ice cream, and raw cheese has met the demand for novelty and change in new tea drinks, customizing a richer and more diverse sensory experience.    . In addition to new tea drinks, the Chinese cheese market has also developed rapidly. On the one hand, young people are living faster-paced lives with increased dining out, “cheese + "Western dining, baking, and other scenarios are penetrating deeper, driving B The Western dining industry is growing continuously; on the other hand, with the trend towards refined family childcare, C The market for end-use cheese is rapidly expanding, especially for children's cheese C The terminal occupies an important position.   "The current premium quality market is driven by the supply of special regional milk sources, rare dairy breeds, innovative technologies, and minimalist formulas, which have promoted the upscale development of the dairy market.    The retail channels for dairy products are diversified, and new retail has accelerated the integration of online and offline sales. Dairy product categories are continuously being refined, greatly enhancing the overall product richness and standardization.    I believe that with ' cheese +' Scenarios such as Western cuisine, baking, and new-style tea drinks are penetrating deeper, and the application scenarios of dairy products will become more extensive, with tremendous market development potential. "Zhang Jian said."

Hong Kong, since the beginning of this year IPO listing The market volume has increased year-on-year, but the fundraising amount has declined.   wind Data shows that as of 6 month 15 day, there is 26 Only stocks listed on the Hong Kong Stock Exchange (excluding two stocks introduced for listing), Hong Kong IPO listing Raising approximately 130 HK$10 billion. Last year, there was only 16 Only stocks are listed, but the raised assets are 140 HK$10 billion.    Since the beginning of this year, there has been 15 The stock has fallen below its issue price. How do you view the slowdown in fundraising for Hong Kong stocks in the first half of the year, and what are the reasons for it?   How do you view the Hong Kong stock market in the second half of this year? IPO listing What is the development situation? Some reforms regarding listing conditions by the Hong Kong Stock Exchange will have an impact on Hong Kong stocks IPO listing What kind of boosting effect does it have?    Frost & Sullivan Frost & Sullivan Dr. Wang Xin, Global Partner and Chairman of Frost & Sullivan Greater China, was interviewed by 'Jiemian News' to discuss the development trends of the Hong Kong stock market. * Click "Read the Original Article" at the end of this text to read the full report. Jiemian News Q In the first half of this year, as of now, Hong Kong stocks IPO listing In the case in question, the number is higher than last year, but the fundraising amount is less. How do you view this phenomenon? What causes the slowdown in fundraising for Hong Kong stocks in the first half of the year?   With the diversification of Hong Kong stock listing methods, such as introduction listings, SPAC , as well as those recently launched 18C , more and more enterprises are choosing to go public in Hong Kong, which is the Hong Kong stock market IPO listing One of the main reasons for the increase in quantity. IPO listing The increase in the number is an acknowledgment by the company of the Hong Kong Stock Exchange and a positive signal from diversified listings, which can attract more domestic and overseas investors. In terms of fundraising, it is mainly affected by the Federal Reserve's interest rate hikes and uncertainties about foreign capital, leading companies to be more restrained in the number of shares issued and the amount raised. Q How do you view the Hong Kong stock market in the second half of this year? IPO listing What is the development situation? Some reforms to listing conditions by the Hong Kong Stock Exchange will have an impact on Hong Kong stocks IPO listing What kind of boosting effect does it have? In recent years, the Hong Kong Stock Exchange has been actively reforming its system, following 18A Subsequently, the new listing rules that were introduced this year allow companies in the fields of next-generation information technology, advanced hardware and software, advanced materials, new energy and environmental protection, new food and agricultural technology to list on the Hong Kong stock market. These rules have broadened the channels for technology companies that are not yet profitable or already supported by revenue to go public in Hong Kong. We expect that after the overall market adjusts and recovers in the second half of the year, it will stabilize and improve. 18C Enterprises going public in Hong Kong are still relatively optimistic about fundraising scale. * This interview was published in "Jiemian News", with reporter Liu Chenguang, and the original title was "   Hong Kong stocks since the beginning of this year IPO listing The volume far exceeds the same period last year, but financing fell. What will happen to the market in the second half of the year?    ">

The 11th International   Hand Sanitization and Protection Products Fair 2023 year 6 month 13 - 14 On the day of, hosted by YMT Information Technology (Yantai) Co., Ltd., co-organized by Shandong Ruibang Intelligent Equipment Co., Ltd., and guided and supported by the Nanjing Hospital Association and China Disposable Gloves Federation, “ 2023 The (11th) International Hand Sanitizer and Protective Equipment Trade Fair was successfully held in Nanjing. The conference brought together more than a hundred disposable glove factories and industry chain exhibitors, providing one-stop procurement services and technical solutions for enterprises in the protective equipment industry chain, and jointly building a platform for communication and cooperation across the entire industry chain. Frost & Sullivan Frost & Sullivan The Executive Director of Frost & Sullivan Greater China region, Mr. Xiang Wei, was invited to attend the conference.   as for    Current Situation and Development Trend of Disposable Gloves Market    Deliver a keynote speech   . Executive Director, Greater China, Frost & Sullivan To power     Pointing out to Wei Li that, looking at the entire industry, the glove industry falls under personal protective equipment ( PPE The personal protective equipment market for racing circuits encompasses gloves, protective clothing, helmets, goggles, and other garments or equipment designed to protect wearers from injury or infection. The overall market size exceeds 1,000 billions, with a very rapid growth rate over the past five years, achieving an annual compound growth rate of 35% . As is well known, COVID-19 pandemic It has had a certain impact on the Chinese economy, with various industries experiencing varying degrees of shock. However, the personal protective equipment market has seen unprecedented rapid growth. In particular, the respiratory system protection products and hand protection products, which consist of masks and gloves, account for a significant portion of the personal protective equipment market. 50% As mentioned above, the market scale exceeds 600 billions. Disposable gloves account for more than 7 Success has almost become the largest segment within the personal protection market. As a commonly used protective item, disposable gloves can effectively prevent cross-infection and are suitable for various occasions. According to quality grades and uses, they can be divided into medical and non-medical types. Medical gloves refer to products that need to meet the quality certification system or access standards of the target country's medical market, mainly used in fields such as medical surgery, medical examinations, and medical care.   Among them, medical gloves accounted for more than 70% , as the product unit price and added value are higher, it accounts for a larger proportion of the total glove shipments based on the shipment amount 83 - 85% . Classified by materials, disposable gloves are mainly divided into PVC Gloves, latex gloves, nitrile gloves PE gloves, etc. PVC Gloves are inexpensive, with the minimum quality grade requirement being low, and the cost is low globally. PVC Glove production capacity 90% In China, nitrile gloves are currently the category with the fastest growth rate in global shipments, with overall shipments almost equaling PVC Gloves in parallel, growth rate over the past five years 18% , it is expected that it can still maintain over in the future 12% growth rate.   To Weili,   Disposable gloves   For rigid demand, the overall market demand will continue to rise. In the past few years   COVID-19 pandemic   Under the influence, the glove industry has witnessed tremendous development. Although the pandemic has had a significant impact on capacity expansion plans and utilization rates, it has directly enhanced people's health awareness, hygiene precautions, and industrial safety standards, laying a foundation for the sustainable development of the disposable glove industry in the future.    In the post-pandemic era, the market is gradually returning to normalcy. The supply and demand relationship and market environment have changed, leading to reduced corporate revenues and profits. Some small and medium-sized manufacturers that entered the market during the pandemic will be gradually phased out, while the growing demand for permanent gloves will continue to drive market growth.   Subsequently, Wei Li briefly analyzed the future growth logic of the global disposable glove industry: 1 The epidemic has driven up people's awareness of personal protection, while also raising labor safety standards for enterprises, gloves / Masks and other disposable personal protective equipment will become necessities in people's daily lives and corporate production and operations in the future. In addition, this will further prompt the country to continuously optimize policies based on specific scenarios, introduce various regulations, strengthen product usage standards, and promote the standardized development of the industry; 2 The recovery and growth of the economy are accompanied by an improvement in people's living standards, which is directly related to the country's investment in health and wellness. Developed regions such as Europe and America have higher living standards and income levels, coupled with strict public health regulations, making them the regions with the largest glove consumption globally. They will continue to be the main export areas in the future;   3 Although China's disposable glove production sector holds a high position internationally, the industry is mainly export-oriented, primarily focusing on OEM/ODM The model exports products to Europe and America. There is huge growth potential for disposable gloves in China as a whole. According to preliminary statistics from Frost & Sullivan, China's annual per capita consumption of disposable gloves is 9 Only, far lower than in the United States 300 Only, the Netherlands' 317 Japan 133 There is still significant room for growth; 4 Although developed countries such as Europe and America still occupy the majority of the market share for disposable gloves, developing countries like China, the Philippines, and Indonesia are expected to make increasingly significant contributions to the growing global glove consumption in the medium to short term, with strong economic development, population growth, and an increasing awareness of the importance of hygiene; 5 In recent years, industry concentration has been continuously rising. Enterprises lacking competitive advantages will be gradually phased out, and the industry will further develop towards standardization and specialization. To enhance their position in the industrial chain, many enterprises have established comprehensive supply chain systems to meet product demands from different global markets, continuously laid out new protective product fields, strengthened overseas factory construction and business center adjustments, and improved production processes and labor productivity to maintain their long-term core competitiveness within the industry.